Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients

Abstract Background Despite the high response rate to PD-1 blockade therapy in metastatic melanoma (MM) patients, a significant proportion of patients do not respond. Identifying biomarkers to predict patient response is crucial, ideally through non-invasive methods such as liquid biopsy. Methods So...

詳細記述

書誌詳細

出版年:	Journal of Experimental & Clinical Cancer Research
主要な著者:	Amalia Azzariti, Simona De Summa, Tommaso M. Marvulli, Ivana De Risi, Giuseppe De Palma, Roberta Di Fonte, Rossella Fasano, Simona Serratì, Sabino Strippoli, Letizia Porcelli, Michele Guida
フォーマット:	論文
言語:	英語
出版事項:	BMC 2025-02-01
主題:	Metastatic melanoma Predictor of anti-PD1 response Anti-PD1 resistance sPD1 sPD-L1 sLAG-3
オンライン･アクセス:	https://doi.org/10.1186/s13046-025-03306-w